DYDX Fades 16.7% Over 30 Days as Price Sits 5.2% Below SMA200
⚖ Verdict rendered 2026-07-24 01:28 UTC
Each grade is scored on its own scale — they are not averaged, by design.
Prices from the archived reports themselves — open either end to check.
Prices from the archived reports themselves — open either end to check.
graded settle_v1, 7d vs BTC — misses stay on the record · full receipts →
Opinions are AI; settlements are facts. · data powered by VeraMind
snapshot at verdict time, computed from exchange data — facts, not opinions · price = median of 5 exchanges
I’ll concede the ugliest number, Mara: DYDX is down 16.7% over 30 days and trades 5.2% under its SMA200. But the tape is trying to turn—MACD histogram is positive and expanding, RSI is only 46.4, and the 60-day low at 0.1103 sits 12.9% below spot; that’s a battered spring, not a fresh collapse.
Leo, your spring is still pinned under three moving averages: price is 1.3% below SMA20, 5.0% below SMA50, and 5.2% below SMA200. A positive MACD histogram of just 0.0004032 does not erase the -16.7% monthly trend, especially when takers sell at a 0.88 buy/sell ratio.
Mara, you’re treating the moving averages like concrete walls, but MACD is already turning upward and seven-day performance is +0.2%. A reclaim of 0.1247 would show sellers are losing the immediate battle.
Leo, 0.1247 is merely today’s high, not a trend reversal. The token remains near the floor of a range whose 60-day high is 0.245, nearly 49.2% above spot; that gap is evidence of damage, not hidden strength.
Mara, you’re treating the moving averages like concrete walls, but MACD is already turning upward and seven-day performance is +0.2%. A reclaim of 0.1247 would show sellers are losing the immediate battle.
Leo, 0.1247 is merely today’s high, not a trend reversal. The token remains near the floor of a range whose 60-day high is 0.245, nearly 49.2% above spot; that gap is evidence of damage, not hidden strength.
Leo, I’m not seeing a positioning squeeze: only 48.4% of long accounts and an L/S ratio of 0.94. Theo’s dry verdict is simple—there are too few crowded longs to fuel the upside, while the 0.88 taker ratio confirms aggressive demand is absent.
I’ll add the macro bruise: with the Clarity Act likely missing its window, there is no regulatory-liquidity catalyst in this pack. Robinhood’s Arcus tie-up is interesting, but the reported 23% token drop says the market is selling the headline.
I award the bearish side. The decisive exhibit is DYDX’s 30-day loss of 16.7% while remaining 5.2% below SMA200; the positive MACD histogram is not enough to overturn that structure. I invalidate this ruling on a sustained break above 0.1247 accompanied by RSI(14) reclaiming 50.
Direction: bearish. Evidence families: price below SMA20/SMA50/SMA200; bearish SMA50–SMA200 structure; 30d return -16.7%. Conflicts: MACD histogram is positive and expanding; RSI 46.4 is neutral. Sufficiency: adequate.
Direction: bearish. Evidence families: Fear&Greed 28; taker buy/sell 0.88; long accounts 48.4% with L/S ratio 0.94. Conflicts: positioning is not heavily long, so forced-long liquidation risk is modest. Sufficiency: adequate.
Robinhood-linked Arcus gives dYdX an ecosystem headline, but the token reportedly dropped 23% around the launch news. The broader tape adds no clean catalyst: the Clarity Act is expected to miss its legislative window, while a hacked Robinhood CEO account adds reputational noise rather than DYDX demand.
Arcus launching on Robinhood Chain is a concrete distribution opportunity for the dYdX ecosystem. The data pack provides no token-supply, revenue, fee-capture, or valuation figures, so the fundamental case cannot override the chart’s sustained weakness.
2026-07-23 · 2026-07-22 · 2026-07-21 · 2026-07-20 · 2026-07-19 · 2026-07-17 · 2026-07-16 · 2026-07-15